Literature DB >> 22370219

Hepatitis B virus, a sex hormone-responsive virus.

Shuping Tong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22370219      PMCID： PMC6342015          DOI： 10.1053/j.gastro.2012.02.036

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  21 in total

1.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Authors:  Chien-Jen Chen; Hwai-I Yang; Jun Su; Chin-Lan Jen; San-Lin You; Sheng-Nan Lu; Guan-Tarn Huang; Uchenna H Iloeje
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

2.  Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.

Authors:  Philip Meuleman; Louis Libbrecht; Rita De Vos; Bernard de Hemptinne; Kris Gevaert; Joël Vandekerckhove; Tania Roskams; Geert Leroux-Roels
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

3.  Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.

Authors:  M W Yu; Y C Yang; S Y Yang; S W Cheng; Y F Liaw; S M Lin; C J Chen
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

4.  Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice.

Authors:  Yanyan Zheng; Wen-ling Chen; Stan G Louie; T S Benedict Yen; Jing-hsiung James Ou
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

5.  Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma.

Authors:  M W Yu; S W Cheng; M W Lin; S Y Yang; Y F Liaw; H C Chang; T J Hsiao; S M Lin; S D Lee; P J Chen; C J Liu; C J Chen
Journal:  J Natl Cancer Inst       Date:  2000-12-20       Impact factor: 13.506

6.  Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.

Authors:  M Dandri; M R Burda; E Török; J M Pollok; A Iwanska; G Sommer; X Rogiers; C E Rogler; S Gupta; H Will; H Greten; J Petersen
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

7.  Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

Authors:  Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

8.  Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

Authors:  H L-Y Chan; A Y Hui; M L Wong; A M-L Tse; L C-T Hung; V W-S Wong; J J-Y Sung
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

9.  Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection.

Authors:  Guohong Deng; Gangqiao Zhou; Yun Zhai; Shuqing Li; Xuhong Li; Ya Li; Ruifang Zhang; Zhijian Yao; Yan Shen; Boqing Qiang; Yuming Wang; Fuchu He
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

10.  Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk.

Authors:  Ming-Whei Yu; Hung-Chuen Chang; Shun-Chiao Chang; Yun-Fan Liaw; Shi-Ming Lin; Chun-Jen Liu; Shou-Dong Lee; Chih-Lin Lin; Pei-Jer Chen; Shee-Chan Lin; Chien-Jen Chen
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425
View more
  6 in total

Review 1.  Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Wei-Cheng Liu; Quan-Yan Liu
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

2.  Polymorphism of estrogen receptor alpha (ESR1) is associated with virological response to entecavir (ETV) in nucleoside-naïve adult patients with chronic hepatitis B.

Authors:  T-T Zhang; J Ye; S-L Xia; Y-F Zhang; Q Su; Z-H Zhang; X Li
Journal:  Infection       Date:  2012-10-30       Impact factor: 3.553

3.  The prevalence and clinicopathological features of breast cancer patients with hepatitis B virus infection in China.

Authors:  He Wu; Chunxia Zhao; Vishnu Prasad Adhikari; Linjie Lu; Jianbo Huang; Yuxian Wei; Qingqing Luo; Wei Dai; Yutuan Wu; Xin Li; Kainan Wu; Ling-Quan Kong
Journal:  Oncotarget       Date:  2017-03-14

Review 4.  Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection.

Authors:  Jiayi Wang; Lingyao Du; Hong Tang
Journal:  Front Med (Lausanne)       Date:  2021-11-24

Review 5.  Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Maurizio Montella; Giovanni D'Arena; Anna Crispo; Mario Capunzo; Flavia Nocerino; Maria Grimaldi; Antonio Barbieri; Anna Maria D'Ursi; Mario Felice Tecce; Alfonso Amore; Massimiliano Galdiero; Gennaro Ciliberto; Aldo Giudice
Journal:  Int J Endocrinol       Date:  2015-09-27       Impact factor: 3.257

6.  Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir.

Authors:  Chien-Hung Chen; Chuan-Mo Lee; Hsueh-Chou Lai; Tsung-Hui Hu; Wen-Pang Su; Sheng-Nan Lu; Chia-Hsin Lin; Chao-Hung Hung; Jing-Houng Wang; Mei-Hsuan Lee; Cheng-Yuan Peng
Journal:  Oncotarget       Date:  2017-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.